Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 17.49 -0.33 (-1.85%) Market Cap: 472.97 Mil Enterprise Value: 251.50 Mil PE Ratio: 0 PB Ratio: 1.83 GF Score: 74/100

Arcturus Therapeutics Holdings Inc at Barclays Global Healthcare Conference Transcript

Mar 16, 2023 / 01:00 PM GMT
Release Date Price: $15.88 (-0.38%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ARCT.OQ - Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc at Barclays Global Healthcare Conference
Mar 16, 2023 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Company Representative, [1]
--------------------------------------------------------------------------------
Well, thank you to Barclays for the invitation to present in here in Miami. I'm happy to give an update of where Arcturus is. Arcturus Therapeutics is a messenger RNA therapeutics and vaccine company.

But we're based in San Diego, and we have about 180 employees. And we have 3 divisions of the company. We have a vaccine division, a liver division and a lung division that each have a flagship asset that leads each of those auxiliaries of the company.

Our OTC program is a rare liver disease. That's our flagship for the liver franchise. We have a CF program called ARCT-032 that leads our lung franchise. And we also have several partnerships, as you
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot